Please login to the form below

axitinib

This page shows the latest axitinib news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s plans for Inlyta go awry with failed adjuvant trial

The ATLAS study was testing whether VEGF inhibitor Inlyta (axitinib) given as an adjuvant treatment after surgery to remove the tumour could improve disease-free survival compared to placebo, but has

Latest news

Good NICE news for Pfizer, but Dendreon drug rejected

NICE has given a final recommendation to Pfizer's new kidney cancer pill Inlyta (axitinib) - but has rejected Dendreon's prostate cancer treatment Provenge (sipuleucel-T).
NICE backs Pfizer drug in kidney cancer

The National Institute for Health and Care Excellence (NICE), which provides healthcare guidance for the NHS, backed the use of Inlyta (axitinib) in advanced kidney cancer two years after turning down ... Although, this recommendation has not changed
Pfizer signs $2.85bn immuno-oncology alliance

Earlier this year, Pfizer signed an agreement with Merck &Co to test Keytruda alongside Xalkori (crizotinib) in patients with NSCLC, breast cancer and melanoma candidate palbociclib and Inlyta (axitinib) in patients
NHS names drugs to be re-evaluated for Cancer Drugs Fund

Bosulif (bosutinib). Leukaemia (3 indications). Inlyta (axitinib). Renal cancer. Xalkori (crizotinib).
Pfizer and Merck expand anti-PD1 cancer alliance

types. The two companies are already testing the drug in combination with Pfizer's renal cell carcinoma therapy Inlyta (axitinib) and breast cancer and melanoma candidate palbociclib, a CDK inhibitor that

More from news
Approximately 7 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Cancer immunotherapy: What's on the horizon?

They include Pfizer’s OX40 agonist PF-04518600, in early-stage testing in combination with the company’s Bavencio (avelumab) and targeted cancer drug Inlyta (axitinib) as well as chemotherapy,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Mirna hires former Pfizer director as CMO

Mirna will be banking on Dr Kim's extensive experience in oncology, which includes serving as global clinical lead for kidney cancer drugs Inlyta (axitinib) and Torisel (temsirolimus) during his time

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Oncology drugs under AMNOG

Pfizer’ s Inlyta (axitinib) was approved in kidney cancer for patients pre-treated with either another targeted therapy, Sutent (sunitinib), or with older drugs called cytokines.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Training Manager - Surrey: Competitive Salary &Bonus

Healthcare PR Senior Account Manager: Salary TBC

Senior Medical Writer, MedComms Agency: Salary TBC

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager: Negotiable

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Account Manager – Healthcare Advertising: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Systematic Review Lead- London: Negotiable

Senior Medical Writer: Salary is DOE

Sudler London - Senior Medical Writer: Competitive

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Sudler London - Account Director: Competitive

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Account Manager- 4 days per week or full-time: Salary TBC

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Associate Scientific Director: Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Graduate Scientific Editor: DOE

Account Director or Senior Account Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....